Gregory Berk - Net Worth and Insider Trading

Gregory Berk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Berk owns 3 companies in total, including Verastem Inc (VSTM) , DNIB Unwind Inc (BINDQ) , and GT Biopharma Inc (GTBP) .

Click here to see the complete history of Gregory Berk’s form 4 insider trades.

Insider Ownership Summary of Gregory Berk

Ticker	Comapny	Transaction Date	Type of Owner
VSTM	Verastem Inc	2016-04-15	Chief Medical Officer
BINDQ	DNIB Unwind Inc	2013-10-24	Chief Medical Officer
GTBP	GT Biopharma Inc	2022-07-15	Pres. of R&D & CMO

Gregory Berk Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory Berk Ownership Network

Ownership Network List of Gregory Berk

No Data

Ownership Network Relation of Gregory Berk

Gregory Berk Owned Company Details

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Gregory Berk is the Chief Medical Officer of Verastem Inc. Other key executives at Verastem Inc include Vice President of Finance Daniel Calkins , Chief Operating Officer Dan Paterson , and Chief Financial Officer Robert E. Gagnon .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Gregory Berk made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 2,240 shares made by Daniel Calkins , a net sale of 39,211 shares made by Robert E. Gagnon , and a net sale of 41,587 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 1,735 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 1,735 shares. During the past 18 months, 108,848 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,848 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verastem Inc Insider Transactions

No Available Data

What does DNIB Unwind Inc do?

Who are the key executives at DNIB Unwind Inc?

Gregory Berk is the Chief Medical Officer of DNIB Unwind Inc. Other key executives at DNIB Unwind Inc include director & other: Chairman Daniel Lynch , Chief Scientific Officer Jonathan Michael Yingling , and director & PRESIDENT & CEO Andrew Hirsch .

DNIB Unwind Inc (BINDQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DNIB Unwind Inc Insider Transactions

No Available Data

What does GT Biopharma Inc do?

Who are the key executives at GT Biopharma Inc?

Gregory Berk is the Pres. of R&D & CMO of GT Biopharma Inc. Other key executives at GT Biopharma Inc include director & Exec. Chair. and Interim CEO Michael Martin Breen , CFO & Secretary Manu Ohri , and Acting Chief Financial Officer Gavin Choy .

GT Biopharma Inc (GTBP) Insider Trades Summary

Over the past 18 months, Gregory Berk made no insider transaction in GT Biopharma Inc (GTBP). Other recent insider transactions involving GT Biopharma Inc (GTBP) include a net purchase of 50,000 shares made by Manu Ohri , and a net purchase of 50,000 shares made by Michael Martin Breen .

In summary, during the past 3 months, insiders sold 0 shares of GT Biopharma Inc (GTBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GT Biopharma Inc (GTBP) were sold and 3,333 shares were bought by its insiders, resulting in a net purchase of 3,333 shares.

GT Biopharma Inc (GTBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

GT Biopharma Inc Insider Transactions

No Available Data

Gregory Berk Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Berk. You might contact Gregory Berk via mailing address: Hana Biosciences, Inc., 400 Oyster Point Blvd, San Francisco Ca 94080.

Discussions on Gregory Berk

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.